Published in PLoS One on October 08, 2013
The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis c outcome. BMC Infect Dis (2015) 1.41
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Emerg Microbes Infect (2014) 0.96
Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions. J Interferon Cytokine Res (2014) 0.78
Association of Overt Diabetes Mellitus with the Non-CC but not the CC Genotype of Interleukin-28B in Hepatitis C Virus Infected Patients. J Clin Transl Hepatol (2016) 0.75
Influence of host resistance on viral adaptation: hepatitis C virus as a case study. Infect Drug Resist (2015) 0.75
Interferon Lambda: Modulating Immunity in Infectious Diseases. Front Immunol (2017) 0.75
Impact of host genetic polymorphisms on vaccine induced antibody response. Hum Vaccin Immunother (2016) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
An integrated map of genetic variation from 1,092 human genomes. Nature (2012) 59.82
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med (2002) 36.55
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature (2009) 26.47
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet (2009) 14.16
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet (2009) 13.03
Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol (2002) 11.99
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A (1989) 11.76
Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol (2005) 9.11
Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med (2008) 9.00
Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect (2011) 6.48
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature (2008) 6.25
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet (2013) 6.19
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology (2006) 6.16
Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene (2006) 4.62
Progress and promise of genome-wide association studies for human complex trait genetics. Genetics (2010) 3.81
IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology (2010) 3.57
IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol (2007) 2.40
Interferon-lambda serum levels in hepatitis C. J Hepatol (2010) 2.28
HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology (2012) 2.08
Hierarchies of NF-κB target-gene regulation. Nat Immunol (2011) 1.71
Hepatic expression of HCV RNA-dependent RNA polymerase triggers innate immune signaling and cytokine production. Mol Cell (2012) 1.61
IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. J Hepatol (2011) 1.32
Host genomics and HCV treatment response. J Gastroenterol Hepatol (2012) 1.30
Defining emerging roles for NF-κB in antivirus responses: revisiting the interferon-β enhanceosome paradigm. PLoS Pathog (2011) 1.27
Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. PLoS One (2010) 1.26
IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One (2012) 1.25
Genetics of IL28B and HCV--response to infection and treatment. Nat Rev Gastroenterol Hepatol (2012) 1.20
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Med (2011) 1.19
Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response. Hepatology (2011) 1.19
Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin. J Clin Virol (2011) 1.13
VPg-primed RNA synthesis of norovirus RNA-dependent RNA polymerases by using a novel cell-based assay. J Virol (2011) 1.06
Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients. PLoS One (2012) 1.05
IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection. Genes Immun (2011) 1.03
Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol (1998) 1.02
Genetic variation of the IL-28B promoter affecting gene expression. PLoS One (2011) 1.01
IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication. J Viral Hepat (2012) 1.01
Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1. Antiviral Res (2011) 1.00
Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells. PLoS Pathog (2013) 0.97
Distinct and overlapping genomic profiles and antiviral effects of Interferon-λ and -α on HCV-infected and noninfected hepatoma cells. J Viral Hepat (2012) 0.97
IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients. World J Gastroenterol (2011) 0.94
A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A. PLoS One (2011) 0.94
Hepatitis C virus NS3/4A protease blocks IL-28 production. Eur J Immunol (2012) 0.90
Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity. Gastroenterol Res Pract (2011) 0.89
Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients. J Gastroenterol (2013) 0.84
Lymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesis. PLoS Pathog (2013) 0.83
Sequence analysis of the IL28A/IL28B inverted gene duplication that contains polymorphisms associated with treatment response in hepatitis C patients. PLoS One (2012) 0.81
Predicting sustained viral response to hepatitis C using a rapid and simple IL28B rs8099917 genotyping assay. Antiviral Res (2012) 0.80
Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem (2004) 3.13
Small molecule modulators of histone acetyltransferase p300. J Biol Chem (2003) 2.74
Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chem Biol (2007) 2.15
Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer (2009) 1.98
Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem (2004) 1.90
Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res (2010) 1.51
Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. Mol Cell Biol (2005) 1.30
Activation of p300 histone acetyltransferase by small molecules altering enzyme structure: probed by surface-enhanced Raman spectroscopy. J Phys Chem B (2007) 1.22
Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription. Mol Cell Biol (2005) 1.22
Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin. J Biol Chem (2009) 1.17
Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance. J Biol Chem (2012) 1.16
Biology of Aurora A kinase: implications in cancer manifestation and therapy. Med Res Rev (2010) 1.15
Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases. Biochim Biophys Acta (2010) 1.13
Mechanism of p300 specific histone acetyltransferase inhibition by small molecules. J Med Chem (2009) 1.11
Transcriptional coactivator PC4, a chromatin-associated protein, induces chromatin condensation. Mol Cell Biol (2006) 1.09
General transcriptional coactivator PC4 activates p53 function. Mol Cell Biol (2004) 1.03
Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis. Oncogene (2005) 1.02
Transcriptional regulation by the acetylation of nonhistone proteins in humans -- a new target for therapeutics. IUBMB Life (2005) 1.01
Reversible acetylation of non histone proteins: role in cellular function and disease. Subcell Biochem (2007) 1.01
Reversible acetylation of chromatin: implication in regulation of gene expression, disease and therapeutics. Biotechnol J (2009) 1.00
Acetylated NPM1 localizes in the nucleoplasm and regulates transcriptional activation of genes implicated in oral cancer manifestation. Mol Cell Biol (2009) 1.00
Intrinsically fluorescent carbon nanospheres as a nuclear targeting vector: delivery of membrane-impermeable molecule to modulate gene expression in vivo. Nano Lett (2008) 1.00
Activation of p53 function by human transcriptional coactivator PC4: role of protein-protein interaction, DNA bending, and posttranslational modifications. Mol Cell Biol (2007) 0.99
Human transcriptional coactivator PC4 stimulates DNA end joining and activates DSB repair activity. J Mol Biol (2008) 0.97
Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy. J Phys Chem B (2007) 0.96
The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription. Nucleic Acids Res (2003) 0.96
Histone variant nucleosomes: structure, function and implication in disease. Subcell Biochem (2007) 0.95
A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice. J Neurosci (2013) 0.95
Visible-near-infrared and fluorescent copper sensors based on julolidine conjugates: selective detection and fluorescence imaging in living cells. Chemistry (2011) 0.94
Identification of a novel inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1)-mediated methylation of histone H3 Arg-17. J Biol Chem (2009) 0.93
The multifunctional protein nucleophosmin (NPM1) is a human linker histone H1 chaperone. Biochemistry (2011) 0.93
Small molecule modulators of histone acetylation and methylation: a disease perspective. Biochim Biophys Acta (2010) 0.92
Human positive coactivator 4 controls heterochromatinization and silencing of neural gene expression by interacting with REST/NRSF and CoREST. J Mol Biol (2010) 0.92
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin. Chembiochem (2005) 0.91
Sanguinarine interacts with chromatin, modulates epigenetic modifications, and transcription in the context of chromatin. Chem Biol (2009) 0.89
p53 regulates its own activator: transcriptional co-activator PC4, a new p53-responsive gene. Biochem J (2007) 0.89
Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo. Mol Cancer (2014) 0.89
Nitric oxide-mediated histone hyperacetylation in oral cancer: target for a water-soluble HAT inhibitor, CTK7A. Chem Biol (2010) 0.88
Implications of small molecule activators and inhibitors of histone acetyltransferases in chromatin therapy. Biochem Pharmacol (2004) 0.86
Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells. BMC Cancer (2013) 0.86
Protein lysine acetylation in cellular function and its role in cancer manifestation. Biochim Biophys Acta (2010) 0.85
Small molecule modulators in epigenetics: implications in gene expression and therapeutics. Subcell Biochem (2007) 0.85
Effect of phosphorylation on the structure and fold of transactivation domain of p53. J Biol Chem (2002) 0.85
Surface-enhanced Raman scattering studies of human transcriptional coactivator p300. J Phys Chem B (2006) 0.85
Specific small-molecule activator of Aurora kinase A induces autophosphorylation in a cell-free system. J Med Chem (2008) 0.85
Post-translational modifications of lysine in DNA-damage repair. Essays Biochem (2012) 0.85
Acetylation of transition protein 2 (TP2) by KAT3B (p300) alters its DNA condensation property and interaction with putative histone chaperone NPM3. J Biol Chem (2009) 0.84
HIV-1 infection induces acetylation of NPM1 that facilitates Tat localization and enhances viral transactivation. J Mol Biol (2011) 0.84
Sequence insertions in the HIV type 1 subtype C viral promoter predominantly generate an additional NF-κB binding site. AIDS Res Hum Retroviruses (2012) 0.83
Acetyltransferases (HATs) as targets for neurological therapeutics. Neurotherapeutics (2013) 0.83
Discussing gene-gene interaction: warning--translating equations to English may result in jabberwocky. Genet Epidemiol (2007) 0.82
Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. Proteomics (2015) 0.82
Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma. Cancer Prev Res (Phila) (2013) 0.82
Chromatin modifications (acetylation/ deacetylation/ methylation) as new targets for HIV therapy. Curr Pharm Des (2006) 0.81
Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study. Circ Cardiovasc Genet (2014) 0.81
Histone chaperones in chromatin dynamics: implications in disease manifestation. Subcell Biochem (2007) 0.81
Surface-enhanced Raman spectroscopic studies of coactivator-associated arginine methyltransferase 1. J Phys Chem B (2008) 0.81
Enhanced DNA dynamics due to cationic reagents, topological states of dsDNA and high mobility group box 1 as probed by PicoGreen. FEBS J (2008) 0.81
Histone H3K14 and H4K8 hyperacetylation is associated with Escherichia coli-induced mastitis in mice. Epigenetics (2012) 0.80
The elusive goal of pedigree weights. Genet Epidemiol (2007) 0.80
Lysine acetylation: the tale of a modification from transcription regulation to metabolism. Chembiochem (2010) 0.80
Probing p300/CBP associated factor (PCAF)-dependent pathways with a small molecule inhibitor. ACS Chem Biol (2013) 0.80
Characterization of nucleolin K88 acetylation defines a new pool of nucleolin colocalizing with pre-mRNA splicing factors. FEBS Lett (2013) 0.80
Inhibition of acetyltransferase alters different histone modifications: probed by small molecule inhibitor plumbagin. J Biochem (2012) 0.79
Peptide-protein interactions suggest that acetylation of lysines 381 and 382 of p53 is important for positive coactivator 4-p53 interaction. J Biol Chem (2011) 0.79
NPM3, a member of the nucleophosmin/nucleoplasmin family, enhances activator-dependent transcription. Biochemistry (2010) 0.79
Modulation of neurogenesis by targeting epigenetic enzymes using small molecules: an overview. ACS Chem Neurosci (2014) 0.78
Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes Control (2013) 0.78
ATP driven clathrin dependent entry of carbon nanospheres prefer cells with glucose receptors. J Nanobiotechnology (2012) 0.78
Analysis of protein acetyltransferase structure-function relation by surface-enhanced raman scattering (SERS): a tool to screen and characterize small molecule modulators. Methods Mol Biol (2013) 0.78
Naphthoquinone-mediated inhibition of lysine acetyltransferase KAT3B/p300, basis for non-toxic inhibitor synthesis. J Biol Chem (2014) 0.78
Minor groove binder distamycin remodels chromatin but inhibits transcription. PLoS One (2013) 0.78
Gene regulatory networks and epigenetic modifications in cell differentiation. IUBMB Life (2014) 0.77
Structural features of human histone acetyltransferase p300 and its complex with p53. FEBS Lett (2012) 0.77
Evident stabilization of the clinical profile in HIV/AIDS as evaluated in an open label clinical trial using a polyherbal formulation. Indian J Med Res (2013) 0.77
Chromatin organization, epigenetics and differentiation: an evolutionary perspective. Subcell Biochem (2013) 0.76
Histone H3K9 acetylation level modulates gene expression and may affect parasite growth in human malaria parasite Plasmodium falciparum. FEBS J (2014) 0.76
Histone acetylation as a therapeutic target. Subcell Biochem (2013) 0.76
Two-dimensional linkage analyses of rheumatoid arthritis. BMC Proc (2007) 0.76
Histone chaperone as coactivator of chromatin transcription: role of acetylation. Methods Mol Biol (2009) 0.76
Linkage mapping of a complex trait in the New York population of the GAW14 simulated dataset: a multivariate phenotype approach. BMC Genet (2005) 0.75
Nano-scale analyses of the chromatin decompaction induced by histone acetylation. Arch Histol Cytol (2010) 0.75
Identification and characterization of nonhistone chromatin proteins: human positive coactivator 4 as a candidate. Methods Mol Biol (2015) 0.75
Cancer: an epigenetic landscape. Subcell Biochem (2013) 0.75
Structure and Dynamics of a 197 bp Nucleosome in Complex with Linker Histone H1. Mol Cell (2017) 0.75
Small molecule modulators of chromatin and coactivators. Biochim Biophys Acta (2010) 0.75
Chemical biology research in India. ACS Chem Biol (2011) 0.75